Photodermatology Photoimmunology & Photomedicine

Photoaging of human skin
pp. 239-244(6)
Authors: Berneburg M.; Plettenberg H.; Krutmann J.

Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point: (Part 1) Calibration of the method
pp. 245-249(5)
Authors: Moyal D.; Chardon A.; Kollias N.

UVA protection efficacy of sunscreens can be determined by thepersistent pigment darkening (PPD) method: (Part 2)
pp. 250-255(6)
Authors: Moyal D.; Chardon A.; Kollias N.

Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test
pp. 256-259(4)
Authors: Stege H.; Budde M.; Grether-Beck S.; Krutmann J.

Reduction of minimal erythema dose by sweating
pp. 260-262(3)
Authors: Moehrle M.; Koehle W.; Dietz K.; Lischka G.

Regulation of TNF production and release in human and mouse keratinocytes and mouse skin after UV-B irradiation
pp. 263-270(8)
Authors: Yarosh D.; Both D.; Kibitel J.; Anderson C.; Elmets C.; Brash D.; Brown D.

UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneousT-cell lymphoma in vivo
pp. 271-277(7)
Authors: von Kobyletzki G.; Heine O.; Stephan H.; Pieck C.; Stücker M.; Hoffmann K.; Altmeyer P.; Mannherz H.G.

Effect of pentoxifylline on sunburn cell formation in a novel supravital human skin model
pp. 278-280(3)
Authors: Simics E.; Mahunka M.; Horkay I.; Bohnert E.; Moll I.; Jung E.G.

What's New in Phototherapy
pp. 281-282(2)
Author: Morison W.L.

Announcements
pp. 283-283(1)

Tenth Annual Meeting of The Photomedicine Society: March 1, 2001